[1]
H. Wong, T. Yau, C. Wai Man, and R. J. Epstein, “Hoarseness during treatment with bevacizumab and other vascular endothelial growth factor signalling inhibitors”, AO, vol. 48, no. 8, pp. 1213–1215, Jan. 2009.